Ubs Group Ag Genprex, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.19 - $0.37 $4,453 - $8,672
23,438 Added 119.11%
43,116 $9,000
Q3 2023

Nov 09, 2023
BUY
$0.37 - $1.04 $3,745 - $10,527
10,123 Added 105.94%
19,678 $7,000
Q2 2023

Aug 11, 2023
SELL
$0.74 - $1.1 $1,251 - $1,860
-1,691 Reduced 15.04%
9,555 $9,000
Q1 2023

May 12, 2023
SELL
$0.76 - $1.78 $113,468 - $265,754
-149,300 Reduced 93.0%
11,246 $10,000
Q4 2022

Feb 08, 2023
SELL
$1.0 - $58.8 $119,788 - $7.04 Million
-119,788 Reduced 42.73%
160,546 $232,000
Q3 2022

Nov 10, 2022
BUY
$1.32 - $58.0 $11,309 - $496,944
8,568 Added 3.15%
280,334 $395,000
Q2 2022

Aug 10, 2022
SELL
$1.28 - $2.31 $492 - $889
-385 Reduced 0.14%
271,766 $378,000
Q1 2022

May 16, 2022
SELL
$1.82 - $3.5 $4,633 - $8,911
-2,546 Reduced 0.93%
272,151 $615,000
Q4 2021

Feb 14, 2022
BUY
$1.21 - $2.7 $5,874 - $13,108
4,855 Added 1.8%
274,697 $360,000
Q3 2021

Nov 15, 2021
BUY
$2.59 - $3.36 $404,752 - $525,084
156,275 Added 137.61%
269,842 $723,000
Q2 2021

Aug 13, 2021
BUY
$3.11 - $4.87 $1,094 - $1,714
352 Added 0.31%
113,567 $380,000
Q1 2021

May 12, 2021
BUY
$3.66 - $7.67 $188,252 - $394,506
51,435 Added 83.26%
113,215 $488,000
Q4 2020

Feb 11, 2021
BUY
$3.03 - $5.51 $174,328 - $317,012
57,534 Added 1355.02%
61,780 $257,000
Q3 2020

Nov 12, 2020
SELL
$2.9 - $4.29 $17,217 - $25,469
-5,937 Reduced 58.3%
4,246 $14,000
Q2 2020

Jul 31, 2020
BUY
$1.99 - $3.64 $8,887 - $16,256
4,466 Added 78.12%
10,183 $32,000
Q1 2020

May 01, 2020
SELL
$0.28 - $6.23 $2,606 - $58,001
-9,310 Reduced 61.96%
5,717 $14,000
Q4 2019

Feb 14, 2020
BUY
$0.24 - $0.75 $3,606 - $11,270
15,027 New
15,027 $4,000
Q3 2019

Nov 14, 2019
SELL
$0.8 - $1.18 $2,840 - $4,189
-3,550 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$1.2 - $1.85 $2,982 - $4,597
2,485 Added 233.33%
3,550 $4,000
Q1 2019

May 14, 2019
SELL
$1.28 - $2.15 $4,204 - $7,062
-3,285 Reduced 75.52%
1,065 $2,000
Q4 2018

Feb 14, 2019
BUY
$1.0 - $2.15 $551 - $1,184
551 Added 14.5%
4,350 $5,000
Q3 2018

Nov 14, 2018
BUY
$2.2 - $8.08 $6,670 - $24,498
3,032 Added 395.31%
3,799 $9,000
Q2 2018

Aug 14, 2018
BUY
$3.84 - $15.9 $2,945 - $12,195
767 New
767 $6,000

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $64.3M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email